Five days after an ovulation-trigger injection following follitropin alfa therapy, a client reports severe pelvic pain, rapid weight gain, dyspnea, and markedly decreased urine output. Which action is the priority?

1 Hold further gonadotropin exposure and obtain urgent evaluation for ovarian hyperstimulation syndrome. ✓ Correct answer
2 Reassure the client that oliguria and breathing difficulty are expected evidence of successful ovulation.
3 Encourage strenuous exercise and fluid restriction to redistribute the accumulating abdominal and chest fluid.
4 Administer another ovulation-trigger dose before the ovaries recover and reassess urine output tomorrow.

Explanation

Severe pelvic pain, rapid weight gain, dyspnea, and oliguria after gonadotropin therapy indicate potentially serious ovarian hyperstimulation syndrome with fluid shifts and cardiopulmonary or thromboembolic risk.

Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Escalate delayed ovarian hyperstimulation syndrome after gonadotropin exposure.

Why this is correct
OHSS can develop after treatment stops and can progress rapidly. Serious cases require cessation of gonadotropins and assessment for hospitalization and supportive management.

Easy analogy or mental picture
Use a closed medication-safety loop: identify the immune or cytotoxic exposure, connect the new findings, interrupt further harm, stabilize the client, and verify the response over time.

Memory hook
Exposure, immune effect, organ toxicity, infection risk, immediate action, and serial reassessment.

NCLEX decision rule
Choose the action that reduces the most immediate medication-related risk while preserving diagnostic evaluation and authorized treatment.

Why the other choices are wrong
Options that continue the exposure, treat only one symptom, or delay reassessment leave the toxic or infectious process active.

References

1DailyMed: GONAL-f (follitropin alfa)Ovarian hyperstimulation syndrome, rapid fluid shifts, respiratory and thromboembolic complications, and urgent evaluation

Clinical scenario

Oncology, transplant, and biologic safety review
Verify the indication, immune status, infection screen, interacting medicines, current organ findings, authorized action, and measurable follow-up.

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

Five days after an ovulation-trigger injection following follitropin alfa therapy, a client reports severe pelvic pain, rapid weight gain, dyspnea, and markedly decreased urine output. Which action is the priority?

In-depth explanation

Clinical scenario

Master the NCLEX-RN with MyMerci